Morgan Stanley (NYSE:MS | MS Price Prediction) just posted one of its strongest quarters on record, and Wall Street is taking notice. Two major analyst firms raised their price targets on MS stock following the Q1 2026 results. For retirement-focused investors asking whether Morgan Stanley belongs in a long-term portfolio, the answer is getting harder to argue against.
Barclays analyst Jason Goldberg raised his price target on Morgan Stanley stock to $230 from $219, keeping an Overweight rating. Goldman Sachs analyst Richard Ramsden lifted his target to $205 from $186, maintaining a Neutral rating. The two firms agree the quarter was exceptional. Major bank stocks are broadly attracting fresh Wall Street attention this earnings season.
| Ticker | Company | Firm | Action | Old Rating | New Rating | Old Target | New Target |
|---|---|---|---|---|---|---|---|
| MS | Morgan Stanley | Barclays | Price Target Raised | Overweight | Overweight | $219 | $230 |
| MS | Morgan Stanley | Goldman Sachs | Price Target Raised | Neutral | Neutral | $186 | $205 |
The Analyst’s Case
Barclays pointed to trading and wealth management results that came in ahead of expectations as the key drivers behind its target hike. The firm’s Overweight stance signals meaningful room to run from current levels. Goldman Sachs noted that Morgan Stanley again delivered results well in excess of its own targets, including a 31% core wealth management pre-tax margin, a 27% core ROTCE, and a 65% core efficiency ratio.
These results beat Morgan Stanley’s own strategic benchmarks across the board. The firm targets a 30% wealth management pre-tax margin and a 20%+ ROTCE, both of which it cleared comfortably. Goldman Sachs staying Neutral despite the target hike suggests it views the stock as fairly valued, even while acknowledging operational excellence.
Company Snapshot
Morgan Stanley is a global investment bank and financial services firm operating across institutional securities, wealth management, and investment management. The firm serves clients across 42 countries with approximately 83,922 employees worldwide. It reported net revenues of $20.58 billion in Q1 2026, up 16% year over year, with net income rising 29% to $5.57 billion.
Morgan Stanley’s Wealth Management segment is the firm’s long-term anchor, now managing $7.34 trillion in total client assets with $118.40 billion in net new assets added in Q1 alone. Morgan Stanley’s goal is reaching $10 trillion or more in total client assets, giving the wealth engine significant runway.
Why the Move Matters Now
MS stock trades at a forward P/E ratio of 16x and has gained 9% year to date through April 15. Morgan Stanley has now beaten consensus EPS estimates for four consecutive quarters; CEO Ted Pick called Q1 a “record quarter.” That consistency matters to long-term investors seeking earnings predictability.
Morgan Stanley stock’s 52-week range runs from $102.04 to $194.59. The Barclays target of $230 implies further upside, while Goldman’s $205 target sits closer to current levels.
What It Means for Your Portfolio
If you believe Morgan Stanley’s wealth management flywheel, strong trading revenues, and disciplined expense management can sustain this momentum, the Barclays case is compelling. The $1 quarterly dividend, declared April 15 and payable May 15, adds income alongside capital appreciation potential. Goldman Sachs staying Neutral reminds us that at these valuations, execution must remain strong.
Retirement-focused investors should watch for whether Morgan Stanley’s wealth management margins hold above 30% in coming quarters and for whether net new asset flows sustain the pace needed to reach that $10 trillion target. The two analyst calls tell a consistent story: Morgan Stanley is performing at an elite level. The only debate is how much of that is already priced in.
Top Gaining Stocks
Top Losing Stocks